ACTEN - About the company
ACTEN is a public company based in Switzerland, founded in 2021. It operates as a Provider of natural gel supplements designed for supporting joint health. The company has 72 active competitors, including 3 funded and 2 that have exited. Its top competitors include companies like MEND, EMN and Interpath Global.
Company Details
Provider of natural gel supplements designed for supporting joint health. These supplements incorporate collagen, organic brown seaweed, zinc, and vitamin C to promote cartilage maintenance and reduce inflammation. The formula is delivered through a gel matrix structure intended to facilitate higher biocompatibility and rapid nutrient absorption. Products are developed for daily consumption by individuals seeking nutritional support for the musculoskeletal system and physical mobility. Each dose is packaged in a single-serve format that requires no mixing or preparation. All components are tested for purity and provide nutritional benefits for bone and connective tissue health.
Key Metrics
Sign up to download ACTEN's company profile
ACTEN's funding and investors
ACTEN has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ACTEN's Competitors and alternates
Top competitors of ACTEN include MEND, EMN and Interpath Global. Here is the list of Top 10 competitors of ACTEN, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | MEND 2014, New York City (United States), Series A | Provider of dietary supplements to manage body immunity power | $34.1M | 60/100 | |
2nd | Developer of clinical-grade nutrition products | $6.2M | 39/100 | ||
3rd | Interpath Global 1998, Ballarat (Australia), Unfunded | Provider of nutritional supplemnets specializing in joint health | - | - | 32/100 |
4th | Rejuvenate 2018, Burlington (Canada), Unfunded | Provider of an amino acid powder supplement to prevent muscle loss in aging adults | - | - | 26/100 |
5th | Applied Health 1997, Scottsdale (United States), Unfunded | Developer of vitamin & supplement products for treating multiple joint pains | - | - | 26/100 |
6th | Fusion Farm 2013, Viterbo (Italy), Unfunded | Developer of nutritional supplements to support bone and muscle health | - | - | 24/100 |
7th | ![]() Physioflexpro 2021, Iceland, Unfunded | Online retailer of supplements formulated for joint comfort and mobility | - | - | 24/100 |
8th | Collagen Msm Plus 2013, Edgware (United Kingdom), Unfunded | Manufactures proprietary joint health formula | - | - | 24/100 |
9th | ![]() KLC Biotech 2021, Kartal (Turkey), Unfunded | Manufacturer of intraarticular injections and various nutritional supplement product formulations | - | - | 24/100 |
10th | Arthrem 2011, Wellington (New Zealand), Unfunded | Manufactures natural ingredients based joint health supplement | - | - | 24/100 |
20th | ![]() ACTEN 2021, Switzerland, Public | Provider of natural gel supplements designed for supporting joint health | - | - | 20/100 |
Looking for more details on ACTEN's competitors? Click here to see the top ones
ACTEN's Investments and acquisitions
ACTEN has made no investments or acquisitions yet.
Reports related to ACTEN
Here is the latest report on ACTEN's sector:
Are you a Founder ?
FAQs about ACTEN
Explore our recently published companies
- Nohhalife - Unfunded company
- TPE Writing Instrument - Lunas based, 2002 founded, Unfunded company
- Souvenirmanufaktur - Berlin based, 2007 founded, Unfunded company
- Creativeballoonsmanufacturing - Unfunded company
- Talasonline - United States based, Unfunded company
- Imprimerie - Canada based, Unfunded company
